Jatinder Kaur Mukker
5PUBLICATIONS
41CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (5)
Sort by Publication Date:
|Feb 10, 2026
An Integrated Nonclinical and Clinical Risk Assessment of the Effects of Investigational ATRi Tuvusertib on QTc Interval in Patients With Solid Tumors.Jatinder Kaur Mukker, Timothy A Yap, Anthony W Tolcher
|Aug 28, 2025
A First-in-Human Study of ATM Inhibitor Lartesertib as Monotherapy in Patients with Advanced Solid Tumors.Lillian L Siu, Timothy A Yap, Sofia Genta
|Oct 24, 2024
Asia-inclusive drug development leveraging principles of ICH E5 and E17 guidelines: Case studies illustrating quantitative clinical pharmacology as a foundational enabler.Hong Lu, Lena Klopp-Schulze, Jatinder Kaur Mukker
|Jul 08, 2024
Role of Clinical Pharmacology in Diversity and Inclusion in Global Drug Development: Current Practices and Industry Perspectives: White Paper.Aarti Sawant-Basak, Shweta Urva, Jatinder Kaur Mukker
|Feb 26, 2024
First-in-Human Study of the Ataxia Telangiectasia and Rad3-Related (ATR) Inhibitor Tuvusertib (M1774) as Monotherapy in Patients with Solid Tumors.Timothy A Yap, Anthony W Tolcher, Ruth Plummer
Pageof 1
Frequent Collaborators
3 joint publications
Timothy A Yap
3 joint publications
Anthony W Tolcher
2 joint publications
Ruth Plummer
2 joint publications
Christine Hicking
2 joint publications
Wei Gao
2 joint publications
Giuseppe Locatelli
2 joint publications
Zoltan Szucs
2 joint publications
Ioannis Gounaris
2 joint publications
Johann S de Bono
2 joint publications
Kosalaram Goteti
